Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer.

[1]  E. Smit,et al.  A phase II study of high dose epirubicin in unresectable non small cell lung cancer. , 1992, British Journal of Cancer.

[2]  R. Wierzbicki,et al.  Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  F. Pannuti,et al.  Activity of high-dose epirubicin in advanced non-small cell lung cancer. , 1991, European journal of cancer.

[4]  M. Kris,et al.  Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .

[5]  E. Lemarié,et al.  A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non‐Small‐Cell Lung Cancer , 1991, American journal of clinical oncology.

[6]  B. Conley,et al.  Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer. , 1987, Cancer treatment reports.

[7]  M. Kris,et al.  Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. , 1986, Cancer treatment reports.

[8]  R. Cardiff,et al.  Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. , 1986, Cancer treatment reports.

[9]  H. Hansen,et al.  Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung. , 1984, European journal of cancer & clinical oncology.

[10]  R. Wittes,et al.  Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. , 1983, Cancer treatment reports.

[11]  F. Ganzina.  4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. , 1983, Cancer treatment reviews.

[12]  A. Carrato,et al.  Fractionated high doses (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL) , 1991 .

[13]  A. Riva,et al.  Phase II study of high-dose epirubicin in non-small cell lung cancer. , 1990, European journal of cancer.

[14]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.